News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
106,154 Results
Type
Article (4239)
Company Profile (22)
Press Release (101893)
Section
Business (31968)
Career Advice (108)
Deals (5248)
Drug Delivery (4)
Drug Development (5395)
Employer Resources (11)
FDA (3198)
Job Trends (2075)
News (46944)
Policy (3870)
Tag
Academia (362)
Alliances (11107)
Alzheimer's disease (280)
Approvals (3198)
Artificial intelligence (40)
Bankruptcy (45)
Best Places to Work (1710)
Breast cancer (23)
Cancer (214)
Cardiovascular disease (14)
Career advice (99)
Clinical research (4069)
Collaboration (97)
COVID-19 (473)
C-suite (18)
Data (116)
Diagnostics (5601)
Earnings (10252)
Events (13281)
Executive appointments (45)
FDA (3281)
Funding (70)
GLP-1 (37)
Government (623)
Healthcare (2888)
Infectious disease (490)
Inflammatory bowel disease (12)
Interviews (12)
IPO (1772)
Job creations (402)
Job search strategy (94)
Layoffs (21)
Legal (527)
Liver cancer (11)
Lung cancer (22)
Manufacturing (29)
Medical device (2428)
Medtech (2428)
Mergers & acquisitions (3493)
Metabolic disorders (19)
Multiple sclerosis (11)
Neuroscience (310)
NextGen Class of 2024 (702)
Non-profit (544)
Northern California (215)
People (8834)
Phase I (1234)
Phase II (1725)
Phase III (1545)
Pipeline (45)
Postmarket research (212)
Preclinical (586)
Prostate cancer (20)
Radiopharmaceuticals (118)
Rare diseases (17)
Real estate (861)
Regulatory (2929)
Research institute (426)
Resumes & cover letters (15)
Southern California (159)
Startups (622)
United States (1861)
Vaccines (28)
Date
Last 7 days (109)
Last 30 days (480)
Last 365 days (5250)
2024 (4808)
2023 (6127)
2022 (10209)
2021 (9617)
2020 (8993)
2019 (6146)
2018 (4853)
2017 (5399)
2016 (5389)
2015 (6109)
2014 (4630)
2013 (4127)
2012 (4435)
2011 (4631)
2010 (4078)
Location
Africa (130)
Arizona (43)
Asia (5279)
Australia (1218)
California (424)
Canada (179)
China (23)
Colorado (27)
Connecticut (36)
Europe (14915)
Florida (53)
Georgia (27)
Illinois (57)
Indiana (12)
Japan (14)
Maine (19)
Maryland (59)
Massachusetts (239)
Michigan (52)
Minnesota (62)
Missouri (15)
New Hampshire (16)
New Jersey (80)
New Mexico (16)
New York (180)
North Carolina (152)
Northern California (215)
Ohio (18)
Pennsylvania (55)
South America (153)
Southern California (159)
Tennessee (13)
Texas (79)
Utah (43)
Virginia (21)
Washington State (38)
Wisconsin (15)
106,154 Results for "interpace diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Interpace Diagnostics Announces New Data Analyzing Imbalance of Short Tandem Repeat Alleles for Pancreatic Cancer Detection Published as an ASCO 2024 Abstract
Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, is proud to announce that new data demonstrating the application of advanced sequencing technologies in pancreatic cancer was published as an e-abstract as part of the 2024 American Society of Clinical Oncology Annual Meeting.
June 4, 2024
·
6 min read
Press Releases
Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
November 4, 2024
·
10 min read
Business
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
Interpace Biosciences, Inc. announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update.
May 9, 2024
·
9 min read
Press Releases
Interpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic Cysts
July 29, 2024
·
6 min read
Business
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the fourth quarter and full year ending December 31, 2023.
March 7, 2024
·
12 min read
Press Releases
Interpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to Nasdaq
October 15, 2024
·
5 min read
Business
Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
August 1, 2024
·
10 min read
Business
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
Interpace Biosciences, Inc. announced financial results for the third quarter ended September 30, 2023 and provided a business and financial update.
November 8, 2023
·
10 min read
Business
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
Interpace Biosciences, Inc. announced financial results for the second quarter ended June 30, 2023 and provided a business and financial update.
August 9, 2023
·
11 min read
Pharm Country
Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly Improved
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant molecular diagnostic tests and pathology services for improved patient diagnosis and management, today announced new clinical validation data for their thyroid cancer test platform which is comprised of a mutation panel (ThyGeNEXT®) and a microRNA (miRNA) risk classifier.
September 1, 2022
·
6 min read
1 of 10,616
Next
